Kora Saúde Participações S.A.

BOVESPA:KRSA3 Voorraadrapport

Marktkapitalisatie: R$475.7m

Kora Saúde Participações Toekomstige groei

Future criteriumcontroles 3/6

Kora Saúde Participações zal naar verwachting groeien in winst en omzet met respectievelijk 86.5% en 6.6% per jaar. De winst per aandeel zal naar verwachting groeien met 84.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 6.4% zijn.

Belangrijke informatie

86.5%

Groei van de winst

84.8%

Groei van de winst per aandeel

Healthcare winstgroei27.7%
Inkomstengroei6.6%
Toekomstig rendement op eigen vermogen6.4%
Dekking van analisten

Low

Laatst bijgewerkt28 Oct 2024

Recente toekomstige groei-updates

Recent updates

Kora Saúde Participações S.A.'s (BVMF:KRSA3) Shares Climb 26% But Its Business Is Yet to Catch Up

Nov 06
Kora Saúde Participações S.A.'s (BVMF:KRSA3) Shares Climb 26% But Its Business Is Yet to Catch Up

Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Oct 28
Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Kora Saúde Participações S.A.'s (BVMF:KRSA3) Business And Shares Still Trailing The Industry

Sep 21
Kora Saúde Participações S.A.'s (BVMF:KRSA3) Business And Shares Still Trailing The Industry

Revenues Working Against Kora Saúde Participações S.A.'s (BVMF:KRSA3) Share Price Following 25% Dive

Jun 13
Revenues Working Against Kora Saúde Participações S.A.'s (BVMF:KRSA3) Share Price Following 25% Dive

Does Kora Saúde Participações (BVMF:KRSA3) Have A Healthy Balance Sheet?

May 23
Does Kora Saúde Participações (BVMF:KRSA3) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Kora Saúde Participações S.A.'s (BVMF:KRSA3) 26% Share Price Plunge

Apr 16
Why Investors Shouldn't Be Surprised By Kora Saúde Participações S.A.'s (BVMF:KRSA3) 26% Share Price Plunge

Little Excitement Around Kora Saúde Participações S.A.'s (BVMF:KRSA3) Revenues As Shares Take 25% Pounding

Feb 06
Little Excitement Around Kora Saúde Participações S.A.'s (BVMF:KRSA3) Revenues As Shares Take 25% Pounding

There Are Reasons To Feel Uneasy About Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital

Jan 17
There Are Reasons To Feel Uneasy About Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital

Kora Saúde Participações S.A. (BVMF:KRSA3) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Dec 05
Kora Saúde Participações S.A. (BVMF:KRSA3) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Should You Investigate Kora Saúde Participações S.A. (BVMF:KRSA3) At R$1.17?

Sep 07
Should You Investigate Kora Saúde Participações S.A. (BVMF:KRSA3) At R$1.17?

Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital Not Reflecting Well On The Business

Jul 24
Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital Not Reflecting Well On The Business

Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Jan 10
Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Kora Saúde Participações S.A. (BVMF:KRSA3) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Apr 04
Kora Saúde Participações S.A. (BVMF:KRSA3) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Winst- en omzetgroeiprognoses

BOVESPA:KRSA3 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (BRL Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20262,66772345N/A3
12/31/20252,57034604N/A4
12/31/20242,338-90229N/A3
6/30/20242,289-12064137N/A
3/31/20242,272-145110200N/A
12/31/20232,260-168-325-234N/A
9/30/20232,233-212-137-48N/A
6/30/20232,167-222-159-74N/A
3/31/20232,121-173-314-195N/A
12/31/20222,047-108149281N/A
9/30/20221,923-122-300-158N/A
6/30/20221,736-83-257-132N/A
3/31/20221,524-62-168-57N/A
12/31/20211,262-64-8415N/A
9/30/20211,02914-658N/A
6/30/202186041-883N/A
3/31/202168928-525N/A
12/31/202061216-1725N/A
12/31/2019442-3-70-53N/A
12/31/20182831-50-16N/A
12/31/20172646N/A11N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat KRSA3 de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 10.4% ).

Winst versus markt: Er wordt verwacht dat KRSA3 de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat KRSA3 binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van KRSA3 ( 6.6% per jaar) zal naar verwachting langzamer groeien dan de markt BR ( 8% per jaar).

Hoge groei-inkomsten: De omzet van KRSA3 ( 6.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen KRSA3 zal naar verwachting over 3 jaar laag zijn ( 6.4 %).


Ontdek groeibedrijven